Canada Pension Plan Investment Board
RARE icon

Canada Pension Plan Investment Board’s Ultragenyx Pharmaceutical RARE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,000
Closed -$123K – 1440
2024
Q2 		$123K Sell
3,000
-10
-0.3% -$427 ﹤0.01% 1161
2024
Q1 		$141K Hold
3,010
– – ﹤0.01% 1130
2023
Q4 		$144K Hold
3,010
– – ﹤0.01% 1037
2023
Q3 		$107K Hold
3,010
– – ﹤0.01% 957
2023
Q2 		$139K Hold
3,010
– – ﹤0.01% 949
2023
Q1 		$121K Hold
3,010
– – ﹤0.01% 999
2022
Q4 		$139K Hold
3,010
– – ﹤0.01% 1004
2022
Q3 		$125K Hold
3,010
– – ﹤0.01% 1064
2022
Q2 		$180K Hold
3,010
– – ﹤0.01% 1091
2022
Q1 		$219K Sell
3,010
-2,733
-48% -$190K ﹤0.01% 1081
2021
Q4 		$483K Sell
5,743
-5,359
-48% -$436K ﹤0.01% 1105
2021
Q3 		$1M Buy
11,102
+9,180
+478% +$830K ﹤0.01% 999
2021
Q2 		$183K Buy
1,922
+412
+27% +$42.9K ﹤0.01% 963
2021
Q1 		$172K Buy
1,510
+1,500
+15,000% +$204K ﹤0.01% 1163
2020
Q4 		$1K Sell
10
-6,100
-100% -$724K ﹤0.01% 1336
2020
Q3 		$502K Sell
6,110
-13,990
-70% -$1.16M ﹤0.01% 827
2020
Q2 		$1.57M Sell
20,100
-500
-2% -$33.1K ﹤0.01% 801
2020
Q1 		$915K Hold
20,600
– – ﹤0.01% 877
2019
Q4 		$880K Buy
20,600
+8,404
+69% +$347K ﹤0.01% 1069
2019
Q3 		$522K Sell
12,196
-6,204
-34% -$337K ﹤0.01% 1040
2019
Q2 		$1.17M Buy
+18,400
New +$1.17M ﹤0.01% 1021
2018
Q1 		– Sell
-6,300
Closed -$292K – 1277
2017
Q4 		$292K Buy
6,300
+100
+2% +$4.9K ﹤0.01% 1057
2017
Q3 		$330K Buy
+6,200
New +$367K ﹤0.01% 1017
2017
Q1 		– Sell
-5,000
Closed -$352K – 1148
2016
Q4 		$352K Sell
5,000
-1,300
-21% -$92.2K ﹤0.01% 894
2016
Q3 		$447K Buy
+6,300
New +$402K ﹤0.01% 887

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Canada Pension Plan Investment Board's RARE Position: Q3 2024 in Review

Canada Pension Plan Investment Board sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2024, closing a stake of 3,000 shares — an estimated $123K sold.

Canada Pension Plan Investment Board first reported a position in RARE in Q3 2016 and held it in 25 quarters. The position peaked at $1.57M in Q2 2020. 301 funds tracked by Wall St. Rank hold RARE as of Q3 2024.

  • Canada Pension Plan Investment Board reported no remaining Ultragenyx Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 3,000 Ultragenyx Pharmaceutical shares in Q3 2024, an estimated $123K.
  • Canada Pension Plan Investment Board first reported a position in Ultragenyx Pharmaceutical in Q3 2016 and held it in 25 quarters.
  • Canada Pension Plan Investment Board's Ultragenyx Pharmaceutical position peaked at $1.57M in Q2 2020.
  • 301 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2024.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.